Lymphoma is a complex group of blood cancers that are challenging to diagnose and treat with current treatments. Hackensack Meridian Health knows this and has become a leader in lymphoma research. It’s committed to creating better therapies and inspiring hope for patients worldwide.
Lymphoma Research Through Hackensack Meridian Health
At the heart of Hackensack Meridian Health’s lymphoma research is a commitment to progress. This center has one of the largest lymphoma programs in New Jersey, and our researchers and clinicians are at the forefront of discovering new treatments and therapies.
Our comprehensive approach includes:
- Molecular analysis to ensure accurate diagnosis and create personalized treatments
- Phase I, II, and III clinical trials through our partnership with the Georgetown Lombardi Comprehensive Cancer Center
- Stem cell transplant programs that offer patients more hope for remission and prolonged survival.
Through these initiatives, Hackensack Meridian Health is fighting the battle against lymphoma, providing patients access to promising therapies that aren’t available elsewhere.
Support The Eileen Fund’s Mission
At The Eileen Fund, we’re committed to supporting Hackensack Meridian Health’s research. If you’re ready to change the future of lymphoma care, consider donating to our cause today.